March 13, 2024 · Form 4 insider transaction
Fox Jennifer Lynne bought 125,000 shares of Emergent BioSolutions Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Vests in three equal installments beginning on the day prior to the anniversary date of the grant.